Search
Meet the man who helped make the Gerstner Sloan Kettering Graduate School of Biomedical Sciences a reality.
A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.
Beginning in April 2013, physician-scientist Charles Sawyers will serve as President of the American Association for Cancer Research, the world’s oldest and largest professional organization dedicated to advancing cancer research.
Research in blood stem cells has revealed new information about how these cells decide what to become when they divide.
A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.
A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.
The new findings suggest the need for caution when interpreting the results from these tests.
Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
The cBioPortal for Cancer Genomics, developed by computational biologists at MSK more than a decade ago, provides valuable data on the genetic makeup of tumors for the broader cancer community.
Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.